Anxiety treatment: Updated options

Meditsinskiy sovet = Medical Council, Journal Year: 2025, Volume and Issue: 3, P. 111 - 116

Published: April 12, 2025

Generalized anxiety disorder and other spectrum disorders constitute the category of most common mental disorders. Three lines pharmacological therapy are used in treatment disorders: 1) selective serotonin reuptake inhibitors (SSRI) norepinephrine (SNRI); 2) benzodiazepines; 3) antipsychotics. Along with SSRI SNRI, groups antidepressants disorders, drugs anxiolytic properties, such as pregabalin, being considered alternatives to benzodiazepines. Drugs each three categories characterized by both advantages disadvantages that limit their clinical use, which determines need find new treatments for One modern promising generalized is Aviandr, was designated AVN-101 CD-008-0045 at stages development initial testing. The efficacy safety Aviandr has been proven results randomized controlled trials; addition, effectiveness drug improving condition patients who have suffered from acute coronavirus infection noted. In addition its effect, shows ability reduce depressive symptoms exhibits a number additional effects. A notable feature gives it over traditional comparable effectiveness, absence daytime sleepiness, often occurs when benzodiazepines prescribed, side effects typical SSRI.

Language: Английский

Generalization of exposure therapy: Systematic review and recommendations for future research

Behaviour Research and Therapy, Journal Year: 2025, Volume and Issue: unknown, P. 104751 - 104751

Published: April 1, 2025

Language: Английский